drugset / Trial / NCT00004206

Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer

NCT00004206 ↗

Phase 2 Unknown University of Leicester
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining oxaliplatin and fluorouracil in treating patients who have recurrent ovarian cancer.

Timeline

Start
1999-09
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule — Intravenous
Subject fluorouracil Small molecule — Intravenous
Background Leucovorin Small molecule — Intravenous

Indications